In obesity, elevated BCAAs may arise from reduced skeletal muscle oxidation and incomplete catabolism, contributing to mTOR activation and insulin resistance; however, in overt diabetes, enhanced proteolysis and altered gut microbiota activity can accelerate their depletion. The gene discussed is MTOR; the disease is obesity disorder.